Veterinary Medicines

Furosivet 20 mg Tablets for Dogs and Cats

Authorised
  • Furosemide
Download as PDF

Product identification

Medicine name:
Furosivet 20 mg Tablet for Dogs and Cats
Furosivet 20 mg Tablets for Dogs and Cats
Active substance:
  • Furosemide
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    20.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • White high-density polyethylene container containing 250 tablets, with a silica gel bag desiccant, and sealed with a white, child-resistant, polypropylene closure.
  • Cardboard box of 1 Aluminium-PVC foil/PVC-PVDC blister of 10 tablets.
  • Cardboard box of 2 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 3 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 4 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 5 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 6 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 7 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 8 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 9 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 10 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 12 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 15 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 25 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.
  • Cardboard box of 50 Aluminium-PVC foil/PVC-PVDC blisters of 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Millpledge Europe
Marketing authorisation date:
Manufacturing sites for batch release:
  • Millpledge Europe
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 61300/3002
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0329/001
Concerned member states:
  • Belgium
  • France
  • Germany
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 8/01/2025
Download